Search

Author/Creator Levis, Mark

11. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial. Issue 7 (July 2018)

Authors:
Cortes, Jorge; Perl, Alexander E; Döhner, Hartmut; Kantarjian, Hagop; Martinelli, Giovanni; Kovacsovics, Tibor; Rousselot, Philippe; Steffen, Björn; Dombret, Hervé; Estey, Elihu; Strickland, Stephen; Altman, Jessica K; Baldus, Claudia D; Burnett, Alan; Krämer, Alwin; Russell, Nigel; Shah, Neil P;...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 7(2018)
Page Start:
889
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study. Issue 8 (August 2017)

Authors:
Perl, Alexander E; Altman, Jessica K; Cortes, Jorge; Smith, Catherine; Litzow, Mark; Baer, Maria R; Claxton, David; Erba, Harry P; Gill, Stan; Goldberg, Stuart; Jurcic, Joseph G; Larson, Richard A; Liu, Chaofeng; Ritchie, Ellen; Schiller, Gary; Spira, Alexander I; Strickland, Stephen A; Tibes, Ra...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 8(2017:Aug.)
Page Start:
1061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia. Issue 9 (31st August 2018)

Authors:
Ohanian, Maro; Garcia‐Manero, Guillermo; Levis, Mark; Jabbour, Elias; Daver, Naval; Borthakur, Gautam; Kadia, Tapan; Pierce, Sherry; Burger, Jan; Richie, Mary Ann; Patel, Keyur; Andreeff, Michael; Estrov, Zeev; Cortes, Jorge; Kantarjian, Hagop; Ravandi, Farhad
Journal:
American journal of hematology
Issue:
Volume 93:Issue 9(2018:Sep.)
Page Start:
1136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia. Issue 35 (10th December 2022)

Authors:
Daver, Naval; Perl, Alexander E.; Maly, Joseph; Levis, Mark; Ritchie, Ellen; Litzow, Mark; McCloskey, James; Smith, Catherine C.; Schiller, Gary; Bradley, Terrence; Tiu, Ramon V.; Naqvi, Kiran; Dail, Monique; Brackman, Deanna; Siddani, Satya; Wang, Jing; Chyla, Brenda; Lee, Paul; Altman, Jessica K.
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 35(2022)
Page Start:
4048
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗